Hot Investor Mandate 10: Government Organization Invests in Life Science Companies with China Representation

19 Oct

An investment vehicle founded by a regional government agency in China focuses on scientific research, technology transfer, and commercialization. The firm is seeking new life science technologies through investment, licensing, or research collaboration. The firm can make equity investment of up to RMB 10M (US$1.5M) from its two funds of RMB 100M (US$15M) each. The firm is currently looking for China-based opportunities and overseas teams that are Chinese-led or have representatives in China.

The firm considers across several sectors including therapeutics, medical devices, diagnostics, and digital health. Within therapeutics, the firm is interested in cancer immunotherapy and infectious diseases. The firm is also interested in Anesthesia consumables, IVF related technologies and devices, orthopedic devices, wound and trauma care (within medical devices), IVD (within diagnostics), and artificial intelligence (within digital health). The firm is seeking products that have obtained or are close to obtaining FDA approval/clearance. The firm aims to advance the project through development milestones and CFDA registration process in China.

The firm is looking for Chinese-led teams or companies that have representatives in China. In addition to financial investment, the firm can also provide incubation space and R&D support.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: